GENE ONLINE|News &
Opinion
Blog

Special
Special BIOplus
BIX 2022 – Opening Doors to Korea’s Biopharmaceutical Industry
2022-07-27
Special Moderna
Innovating Drug Delivery Systems with Moderna’s Bob Langer
2022-07-26
Special Alzheimer's Disease
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
Partnerships BIO Asia-Taiwan
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26Partner
Special BIO2022
With Precision Health its new focus, Taiwan Shines at BIO 2022 Global Innovation HUB Presentations
2022-07-23
Special Poliovirus
First Polio Case in the US Since 2013 Has Been Detected in New York
2022-07-22
Special Pfizer
Pfizer and Flynn Fined £70 Million in Epilepsy Drug Price Hike Scheme
2022-07-22
Special 2022 psychedelics
Shifting From Counterculture to Clinical Applications, The Problems Psychedelics Face Getting to Market
2022-07-22
Interviews Japan
How the Greater Tokyo Region Could Be the Next Promising Biocommunity
2022-07-19
Special 2022 Single Cell Sequencing
How Single Cell Sequencing is Advancing Biomedical Research
2022-07-15
Special Gene and Cell Therapy
Gene & Cell Therapy’s Big Leaps in the Past 5 Years
2022-07-08
Licensing mRNA Vaccine
CureVac Files mRNA Patent Lawsuit Against BioNTech in Germany
2022-07-06
Funding
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
Special
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
In-Depth FDA
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
1 … 8 9 10 11 12 … 20
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top